Related Experiment Video

Updated: Jun 5, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

Neonatal IVH--mechanisms and management

Gili Kenet1, Amir A Kuperman, Tzipora Strauss

  • 1Thrombosis Unit, National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel. Gili.kenet@sheba.health.gov.il

Thrombosis Research
|January 26, 2011
PubMed

Insights

Intra-ventricular hemorrhage (IVH) is common in premature infants, often causing neurological deficits. This review covers IVH epidemiology, pathogenesis, and potential pro-coagulant therapies for newborns.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Hematology

Background:

  • Intra-ventricular hemorrhage (IVH) predominantly affects very low birth weight premature infants.
  • While advances in care have reduced IVH incidence and mortality, improved survival rates in small premature infants increase the population at risk.
  • Survivors of severe IVH often face significant long-term neurological deficits.

Purpose of the Study:

  • To address the epidemiology and pathogenesis of intra-ventricular hemorrhage (IVH).
  • To review existing studies on potential pro-coagulant therapies for IVH.

Main Methods:

  • Literature review of studies on IVH epidemiology.
  • Review of research on the multifactorial pathogenesis of IVH.
  • Synthesis of studies investigating pro-coagulant therapeutic strategies.

Main Results:

  • IVH pathogenesis is multifactorial, involving germinal matrix prematurity, cerebral blood flow fluctuations, hypoxic-ischemic injury, and neonatal hemostatic abnormalities.
  • Epidemiological data indicates a shift towards an increased population of at-risk newborns due to improved survival rates of small premature infants.
  • Research on pro-coagulant therapy is ongoing.

Conclusions:

  • Intra-ventricular hemorrhage remains a significant concern in neonatal care, particularly for premature infants.
  • Understanding the complex pathogenesis is crucial for developing effective preventative and therapeutic strategies.
  • Further research into pro-coagulant therapies may offer new avenues for managing IVH.

More Related Videos

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...